Why the GSK share price should smash the FTSE 100 this year

Roland Head | Sunday, 10th June, 2018

Roland Head takes a look at FTSE 100 (INDEXFTSE:UKX) climber GlaxoSmithKline plc (LON:GSK) and highlights another turnaround opportunity. More »

Is GSK’s share price the Footsie bargain of 2018?

Peter Stephens | Friday, 8th June, 2018

Does GlaxoSmithKline plc (LON: GSK) offer a potent risk/reward ratio for the long term? More »

Why I’d still buy FTSE 100 giant GlaxoSmithKline but avoid this growth stock

G A Chester | Monday, 4th June, 2018

G A Chester sees reasons to shun a small-cap growth stock with an uncertain outlook in favour of GlaxoSmithKline plc (LON:GSK). More »

Why I’d buy this growth stock alongside GlaxoSmithKline

Kevin Godbold | Tuesday, 1st May, 2018

Defensive dividend income from GlaxoSmithKline plc (LON: GSK) could complement this stock’s growth potential.   More »

2 stocks I’d buy and hold for the next 20 years

Alan Oscroft | Friday, 27th April, 2018

If you had to decide on 2 shares to buy now but were not allowed to sell them for 20 years, what would you... More »

GlaxoSmithKline’s share price and 5% dividend yield make it my buy of the decade

Harvey Jones | Wednesday, 25th April, 2018

Harvey Jones says the combination of a cut price valuation and 5% plus yield make GlaxoSmithKline plc (LON: GSK) a rare opportunity for long-term... More »

Why GlaxoSmithKline’s share price could be about to skyrocket

Ian Pierce | Saturday, 14th April, 2018

A 5%+ yield, double-digit profit growth, improving balance sheet and dirt-cheap valuation put GlaxoSmithKline plc (LON: GSK) in a fantastic position. More »

GlaxoSmithKline’s share price is rising. Is it time to buy?

Edward Sheldon | Monday, 9th April, 2018

GlaxoSmithKline plc's (LON: GSK) share price has bounced 10% in the last few weeks. Is now the time to take a closer look at... More »

Why I believe the GlaxoSmithKline share price is now too cheap to ignore

Rupert Hargreaves | Sunday, 8th April, 2018

I believe the GlaxoSmithKline plc (LON: GSK) share price can only go up from here. More »

GlaxoSmithKline plc isn’t the only pharma stock I’d buy today

Royston Wild | Friday, 6th April, 2018

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune. More »

Top shares for April

The Motley Fool Staff | Sunday, 1st April, 2018

We asked our analysts to share their top stock picks for the month. More »

Why I’d buy 6% yielder GlaxoSmithKline plc for my ISA after this news

Roland Head | Tuesday, 27th March, 2018

A new deal has lifted the GlaxoSmithKline plc (LON:GSK) share price. Roland Head explains why he'd rate the stock as a buy. More »

GlaxoSmithKline plc isn’t the only pharma stock worth investing in for retirement

Peter Stephens | Monday, 5th March, 2018

This company could generate high returns alongside GlaxoSmithKline plc (LON:GSK) (GSK.L). More »

Is Footsie dividend stalwart GlaxoSmithKline plc’s dividend under threat?

Paul Summers | Sunday, 11th February, 2018

Here's why recent positive numbers from pharma giant GlaxoSmithKline plc (LON:GSK) may not be enough to prevent it from cutting its prized dividend. More »

Why I’d buy and hold dividend stocks GlaxoSmithKline plc & Taylor Wimpey plc

Alan Oscroft | Saturday, 10th February, 2018

GlaxoSmithKline plc (LON: GSK) and Taylor Wimpey plc (LON: TW) could be among the best dividend payers of the next decade. More »

Are GlaxoSmithKline plc shares a bargain after FY2017 results?

Edward Sheldon | Thursday, 8th February, 2018

GlaxoSmithKline plc (LON: GSK) currently yields 6.1% and trades on a P/E of 11.8. Does that make the shares a 'buy'? More »

Why I’d avoid this 4.5% dividend yielder and buy GlaxoSmithKline plc instead

Kevin Godbold | Tuesday, 6th February, 2018

This 4.5% dividend yielder may look attractive, but here’s why my money would go on GlaxoSmithKline plc (LON: GSK) More »

One 5% yielder I’d consider over GlaxoSmithKline plc

Jack Tang | Sunday, 4th February, 2018

Are you considering alternative dividend picks amid an earnings plateau at GlaxoSmithKline plc (LON:GSK)? More »

GlaxoSmithKline plc isn’t the only Footsie dividend stock I’d buy today

Royston Wild | Sunday, 28th January, 2018

Royston Wild explains why GlaxoSmithKline (LON: GSK) isn't the only income star that could make you a fortune. More »

GlaxoSmithKline plc isn’t the only unloved dividend stock I’d buy and hold forever

Roland Head | Thursday, 25th January, 2018

Roland Head explains why now could be the time to start buying GlaxoSmithKline plc (LON:GSK). More »